K192046

Substantially Equivalent

LIAISON XL Zika Capture IgM II and LIAISON XL Zika Capture IgM II Control Set

Applicant: DiaSorin, Inc.
Product code: QFO
Advisory panel: Microbiology
Date received: 2019-07-31
Decision date: 2019-10-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Stillwater, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.